MannKind Corporation (MNKD) Fundamentals

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
SHARE INFORMATION
Market Cap$ 957,222,866
Shares Outstanding252,565,400
Float246,959,990
Percent Float97.78%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 75,442,000
Latest Fiscal EPS$ -0.32
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions374
Institutional Holdings Date2022-05-31
Institutional Bought Previous 3 Months10,080,812
Institutional Holdings Percent93.1%
Institutional Sold Previous 3 Months13,477,692
Insider Holdings Date2022-05-31
Insider Bought Previous 3 Months2,227,370
Insider Holdings Percent4.4
Insider Sold Previous 3 Months-
Insider Shares Owned11,081,502
TRADING INFO
52 Week High$ 5.53
52 Week Low$ 2.49
52 Week High Change$ -28.36
21 Day Moving Average$ 4.0576
21 Day Extended Moving Average$ 3.8849
50 Day Moving Average$ 3.6428
50 Day Extended Moving Average$ 3.7833
200 Day Moving Average$ 4.037
200 Day Extended Moving Average$ 3.8559
10 Day Average Volume6,411,600
20 Day Average Volume6,872,939
30 Day Average Volume7,682,827
50 Day Average Volume6,111,943
Alpha0.023618
Beta1.9292
Standard Deviation0.240696
R20.144055
7 Day Price Change$ 0.07
7 Day Percent Change1.88%
21 Day Price Change$ -0.73
21 Day Percent Change-16.15%
30 Day Price Change$ -0.65
30 Day Percent Change-14.64%
Month to Date Price Change$ -0.39
Month to Date Percent Change-9.33%
Quarter to Date Price Change$ 0.11
Quarter to Date Percent Change2.99%
180 Day Price Change$ -0.63
180 Day Percent Change-14.25%
200 Day Price Change$ -0.26
200 Day Percent Change-6.42%
Year to Date Price Change$ -0.58
Year to Date Percent Change-13.27%

MannKind Corporation (MNKD) Key Ratios

PROFITABILITY
EBIT Margin-112.5%
EBITDA Margin-103.8%
Pre-Tax Profit Margin-340.9%
Profit Margin Count-84.01%
Gross Margin55.8%
Profit Margin TOT-84.01%
INCOME STATEMENTS
Revenue$ 69,998,000
Revenue Per Share$ 0.2771
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-4.30
Total Debt To Equity0.00
Int Coverage-5.20
Current Ratio3.40
Leverage Ratio-1.40
Quick Ratio3.20
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-10.70
Enterprise Value$ 1,223,602,984
Price to Sales13.675
Price to Free Cash-12.10
PE High Last 5 Years5.50
Price To Book0.00
Price To Cash Flow26.50
PE Low Last 5 Years-11.70
Price to Tangible Book-4.30
MANAGEMENT EFFECTIVENESS
Receivables Turnover10.00
Invoice Turnover6.60
Assets Turnover0.30
Return Assets-30.83
Return on Equity47.48
Return on Capital0.00

MannKind Corporation (MNKD) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorDeloitte & Touche LLP
CEOMichael E. Castagna
Emplyoees349
Last AuditUQ
CIK0000899460
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address1 Casper Street
Suite 300
Danbury, CT 6810
Websitehttps://www.mannkindcorp.com
Facsimile-
Telephone+1 818 661-5000
Emailir@mannkindcorp.com


Your Recent History
NASDAQ
MNKD
MannKind
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.